Suppr超能文献

对乙酰氨基酚、布洛芬和美洛昔康在放置分离器后超前镇痛效果的比较:一项随机临床试验。

Comparison of the effects of preemptive acetaminophen, ibuprofen, and meloxicam on pain after separator placement: a randomized clinical trial.

作者信息

Zarif Najafi Hooman, Oshagh Morteza, Salehi Parisa, Babanouri Neda, Torkan Sepideh

机构信息

Orthodontic Research Center, Orthodontics Department, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.

Private Practice, Tehran, Iran.

出版信息

Prog Orthod. 2015;16:34. doi: 10.1186/s40510-015-0104-y. Epub 2015 Oct 14.

Abstract

BACKGROUND

This study aims to evaluate and compare the effect of pre-procedural administration of acetaminophen, ibuprofen, and meloxicam in reducing pain after separator placement.

METHODS

Three hundred twenty-one patients who needed orthodontic treatment and aged above 15 were randomly assigned to one of the three study groups: group A: 650 mg acetaminophen, group B: 400 mg ibuprofen, and group C: 7.5 mg meloxicam. All subjects received a single dose of medication 1 h prior to separator placement. Using visual analog scale, patients recorded their pain perception during rest, fitting posterior teeth together, and chewing at time intervals of immediately, 2, 6, 24, and 48 h after separator placement.

RESULTS

There was no significant difference between acetaminophen, ibuprofen, and meloxicam in post-separator placement pain control when administered 1 h before the procedure. In all the groups, at rest, pain level elevated after separator placement and reached its peak at 24 h and then subsided until 48 h. But during chewing and fitting of the posterior teeth, some of the groups reached a peak in pain at 48 h. No significant difference was found in pain experience between males and females.

CONCLUSIONS

Meloxicam can be used as an effective analgesic in orthodontic pain control considering it has less gastric side effects compared to the conventional nonsteroidal anti-inflammatory drugs.

TRIAL REGISTRATION

Iranian Registry of Clinical Trials, IRCT2015041821828N1.

摘要

背景

本研究旨在评估和比较对乙酰氨基酚、布洛芬和美洛昔康在放置分离器前给药对减轻疼痛的效果。

方法

321名年龄在15岁以上需要正畸治疗的患者被随机分配到三个研究组之一:A组:650毫克对乙酰氨基酚;B组:400毫克布洛芬;C组:7.5毫克美洛昔康。所有受试者在放置分离器前1小时接受单剂量药物治疗。使用视觉模拟量表,患者记录了在放置分离器后即刻、2小时、6小时、24小时和48小时休息、后牙咬合以及咀嚼时的疼痛感知。

结果

在放置分离器前1小时给药时,对乙酰氨基酚、布洛芬和美洛昔康在控制放置分离器后的疼痛方面没有显著差异。在所有组中,休息时,放置分离器后疼痛水平升高,在24小时达到峰值,然后在48小时前逐渐减轻。但在咀嚼和后牙咬合时,一些组在48小时时疼痛达到峰值。男性和女性在疼痛体验上没有发现显著差异。

结论

考虑到美洛昔康与传统非甾体抗炎药相比胃肠道副作用较小,它可作为正畸疼痛控制的有效镇痛药。

试验注册

伊朗临床试验注册中心,IRCT2015041821828N1。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f522/4605934/ec541d148f90/40510_2015_104_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验